Trials / Completed
CompletedNCT00733265
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to examine how AZD6140 affects patients with severe kidney disease compared to volunteers with normal kidneys. Subjects in the study will receive one dose of AZD6140.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD6140 | single oral dose |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-08-13
- Last updated
- 2010-12-03
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00733265. Inclusion in this directory is not an endorsement.